Financhill
Back

IGM Biosciences Quote, Financials, Valuation and Earnings

Sell
48

IGMS
IGM Biosciences

Last Price:
9.18
Seasonality Move:
12.17%

7 Day Trial

ALL ACCESS PASS

$ 7

IGM Biosciences Price Quote

$9.18
-0.11 (-1.18%)
(Updated: May 17, 2024 at 6:55 PM ET)

IGM Biosciences Key Stats

Sell
48
IGM Biosciences (IGMS) is a Sell

Day range:
$9.14 - $9.67
52-week range:
$3.81 - $17.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
247.95
P/B ratio:
3.4%

Volume:
133K
Avg. volume:
276K
1-year change:
-27.31%
Market cap:
$548.3M
Revenue:
$2.1M
EPS:
$-4.28

How Much Does IGM Biosciences Make?

Is IGM Biosciences Growing As A Company?

  • What Is IGM Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.05%
  • What Is IGM Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

IGM Biosciences Stock Price Performance

  • Did IGM Biosciences Stock Go Up Last Month?
    IGM Biosciences share price went up by 0.98% last month
  • Did IGMS's Share Price Rise Over The Last Year?
    IGMS share price fell by -27.31% over the past 1 year

What Is IGM Biosciences 52-Week High & Low?

IGM Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy IGM Biosciences?

  • How Much Debt Does IGM Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does IGM Biosciences Have?
    Cash and short term investments quarterly total is $293.8M
  • What Is IGM Biosciences’s Book Value Per Share?
    Book value per share is 2.74

Is IGM Biosciences Cash Flow Positive?

  • What Is IGMS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$183.7M
  • What Is IGM Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $115.1M
  • What Is IGM Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $7.2M

IGM Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    IGMS return on invested capital is -106.11%
  • What Is IGM Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -53.43%
  • What Is IGMS Return On Equity?
    ROE is a measure of profitability and is -106.11%

IGM Biosciences Earnings Date & Stock Price

IGM Biosciences Competitors

  • Who Are IGM Biosciences's Competitors?
    Below is a list of companies who compete with IGM Biosciences or are related in some way:
    • Akoya Biosciences Inc (AKYA)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Xilio Therapeutics Inc (XLO)

IGM Biosciences Dividend Yield

Data Unavailable

IGM Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.35%
Revenue: -4.79% -34.55%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 21.40
Upside from Last Price: 130.36%

Major Shareholders

  • How many IGMS shares are owned by institutional investors?
    32.4M IGMS shares are owned by institutional investors
  • How many IGMS shares are owned by insiders?
    1.1M IGMS shares are owned by insiders